TWD 39.6
(-23.55%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 32.25 Million TWD | 0.0% |
2022 | - TWD | -100.0% |
2021 | 6.99 Million TWD | 4983.6% |
2020 | 137.56 Thousand TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | - TWD | 0.0% |
2024 Q1 | - TWD | -100.0% |
2023 Q4 | 16.12 Million TWD | 0.0% |
2023 FY | 32.25 Million TWD | 0.0% |
2023 Q3 | 16.12 Million TWD | 0.0% |
2023 Q2 | - TWD | 0.0% |
2023 Q1 | - TWD | 0.0% |
2022 FY | - TWD | -100.0% |
2022 Q4 | - TWD | 0.0% |
2022 Q3 | - TWD | 0.0% |
2021 FY | 6.99 Million TWD | 4983.6% |
2020 FY | 137.56 Thousand TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -9703.343% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 91.988% |
Level Biotechnology Inc. | 219.54 Million TWD | 85.309% |
Sagittarius Life Science Corp | 71.47 Million TWD | 54.876% |
NeoCore Technology Co., Ltd. | -9.08 Million TWD | 455.014% |
TaiMed Biologics Inc. | 225.23 Million TWD | 85.68% |
GlycoNex Incorporation | 995 Thousand TWD | -3141.508% |
VBI | 16.42 Million TWD | -96.389% |
GeneReach Biotechnology Corp. | 27.58 Million TWD | -16.926% |
Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 83.748% |
SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -6090.595% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 73.102% |
Visgeneer Inc. | 67.48 Million TWD | 52.205% |
Mycenax Biotech Inc. | -375.19 Million TWD | 108.596% |
Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 97.704% |
G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 77.693% |
Neith Corporation | 18.01 Million TWD | -78.994% |
Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 85.99% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -41.821% |
Enimmune corporation | -23.37 Million TWD | 237.993% |
TaiRx, Inc. | 2.43 Million TWD | -1222.386% |
CHO Pharma, Inc. | -28.27 Million TWD | 214.053% |
EirGenix Inc. | 236.74 Million TWD | 86.376% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 69.092% |
Sunny Pharmtech Inc. | 285.52 Million TWD | 88.704% |
Lin BioScience, Inc. | -17.92 Million TWD | 279.913% |
BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 64.011% |
Feng Chi Biotech Corp. | 80.72 Million TWD | 60.044% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -2878.116% |
Lukas Biomedical Inc. | 133.89 Million TWD | 75.911% |
RBC Bioscience Corporation | 72.89 Million TWD | 55.754% |
BiOptic Inc. | 152.74 Million TWD | 78.884% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -35736.667% |
Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -383.771% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1133.384% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 94.991% |
Advagene Biopharma Co., Ltd. | -12 Million TWD | 368.73% |
NaviFUS Corp. | 11.82 Million TWD | -172.707% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 66.672% |
Sinew Pharma Inc. | -28.98 Million TWD | 211.275% |
Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -10204.473% |
Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 91.782% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 22.246% |
Medigen Biotechnology Corp. | 617.32 Million TWD | 94.775% |
3D Global Biotech Inc. | 5.27 Million TWD | -511.547% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 89.745% |
Intech Biopharm Corporation | -163.99 Million TWD | 119.667% |
Oneness Biotech Co., Ltd. | 32.56 Million TWD | 0.949% |
Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 900.521% |
TWi Biotechnology, Inc. | -9.73 Million TWD | 431.174% |
Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 93.347% |
TCI GENE Inc. | 174.61 Million TWD | 81.529% |
MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 294.283% |
Senhwa Biosciences, Inc. | -10.17 Million TWD | 417.045% |
Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 57.761% |
NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 58.093% |
PharmaEngine, Inc. | 718.97 Million TWD | 95.514% |
Savior Lifetec Corporation | 220.94 Million TWD | 85.403% |
TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 71.122% |
OBI Pharma, Inc. | -73.49 Million TWD | 143.883% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 76.775% |
Acepodia, Inc. | 16.59 Million TWD | -94.377% |
Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -17.416% |